Low plasma and tissue concentrations of PUFAs such as EPA, DHA, and AA can decrease secretion of adiponectin (298, 299) that can aggravate insulin resistance and enhance the chances of development of type 2 DM. The gene discussed is ADIPOQ; the disease is Insulin resistance.